Stocksigma LogoStocksigma Logo

Gland Pharma Appoints Xiao Le as Chief Investment Officer for Singapore Subsidiary

Gland Pharma Limited has appointed Mr. Xiao Le as Chief Investment Officer of its wholly-owned subsidiary, Gland Pharma International Pte

Gland Pharma Appoints Xiao Le as Chief Investment Officer for Singapore Subsidiary

Gland Pharma Ltd 路 Change in Management 路 09 Nov 2026, 3:25 pm

Gland Pharma Appoints Xiao Le as Chief Investment Officer for Singapore Subsidiary Gland Pharma Limited has appointed Mr. Xiao Le as Chief Investment Officer of its wholly-owned subsidiary, Gland Pharma International Pte. Ltd., effective 9th Nov'26. Reporting to the subsidiary's CEO, Mr. Xiao will oversee global investment opportunities and bolster M&A capabilities across the US, China, and Singapore. He brings over 15 years of healthcare investment and asset management experience, having previously held senior M&A and finance roles at WuXi AppTec, MegaRobo Technologies, and Bank of America Merrill Lynch.

Original exchange filing (PDF)

More announcements from Gland Pharma Ltd

All Gland Pharma Ltd announcements